PCOR:NYSEProcore Technologies, Inc. Analysis
Data as of 2026-07-06 - not real-time
$44.04
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Procore Technologies is trading below its short‑term and intermediate moving averages, indicating short‑term weakness, yet the MACD histogram has turned positive and volume is rising, suggesting a potential bounce off the identified support level. The RSI hovers around the neutral midpoint, reinforcing the lack of extreme momentum, while the 30‑day volatility remains elevated, reflecting a turbulent price environment. Fundamentals show solid top‑line growth and a healthy cash position, but profitability remains negative and margins are thin, keeping earnings pressure high. The discounted cash flow model places intrinsic value near the current market price, implying the stock is fairly valued at present, with a sizable upside potential relative to its downside risk.
The sector’s growth narrative, driven by AI‑enhanced construction software, aligns with the company’s recent strategic acquisition, but execution risk and a high price‑to‑book multiple temper enthusiasm. Investors should weigh the bullish technical signs against the lingering earnings challenges and sector volatility when deciding on exposure.
The sector’s growth narrative, driven by AI‑enhanced construction software, aligns with the company’s recent strategic acquisition, but execution risk and a high price‑to‑book multiple temper enthusiasm. Investors should weigh the bullish technical signs against the lingering earnings challenges and sector volatility when deciding on exposure.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- price approaching a clear technical support zone
- bullish MACD histogram indicating momentum shift
- rising trading volume supporting a potential rebound
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- sustained revenue growth and expanding cash reserves
- forward earnings estimates turning positive
- DCF fair‑value estimate aligning with current market price
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- ongoing profitability challenges and thin margins
- high price‑to‑book multiple relative to peers
- execution risk surrounding AI integration and recent acquisition
Key Metrics & Analysis
Financial Health
Revenue Growth15.70%
Profit Margin-5.61%
P/E Ratio20.9
ROE-6.46%
ROA-2.74%
Debt/Equity7.75
P/B Ratio5.5
Op. Cash Flow$311.0M
Free Cash Flow$246.1M
Industry P/E36.6
Technical Analysis
TrendBearish
RSI50.7
Support$38.03
Resistance$52.00
MA 20$42.15
MA 50$47.71
MA 200$61.33
MACDBullish
VolumeIncreasing
Fear & Greed Index93.63
Valuation
Fair Value$44.48
Target Price$69.00
Upside/Downside56.68%
GradeFair
TypeGrowth
Risk Assessment
Beta1.02
Volatility59.31%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.